Cargando…
Role of Postnatal Corticosteroids in the Treatment or Prevention of Bronchopulmonary Dysplasia
As the frequency of viable low birth weight preterm babies increases, bronchopulmonary dysplasia (BPD), one of the most important morbidities in these babies, also increases. Using postnatal steroids to reduce the development of BPD has not been fully enlightened. Besides all prevention strategies f...
Autores principales: | Bulbul, Ali, Bacak, Tolga, Avsar, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Med Bull Sisli Etfal Hosp
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600625/ https://www.ncbi.nlm.nih.gov/pubmed/37899802 http://dx.doi.org/10.14744/SEMB.2023.80688 |
Ejemplares similares
-
Evaluating the use of corticosteroids in preventing and treating bronchopulmonary dysplasia in preterm neonates
por: Olaloko, Oreoluwa, et al.
Publicado: (2018) -
Systemic postnatal corticosteroid use for the prevention of bronchopulmonary dysplasia and its relationship to early neurodevelopment in extremely preterm infants
por: Esterman, Emilia, et al.
Publicado: (2023) -
Postnatal corticosteroid use for prevention or treatment of bronchopulmonary dysplasia in England and Wales 2012–2019: a retrospective population cohort study
por: Yao, Sijia, et al.
Publicado: (2022) -
Utilization of Inhaled Corticosteroids for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L., et al.
Publicado: (2014) -
Postnatal steroid management in preterm infants with evolving bronchopulmonary dysplasia
por: Htun, Zeyar T., et al.
Publicado: (2021)